Journals to Require Clinical-Trial Reports

Responding to growing concern that drug companies may be concealing unfavorable results of experiments, 11 of the world's top medical-research journals have announced that they will require disclosure of continuing clinical trials in a public registry.

The editors of The Journal of the American Medical Association, The New England Journal of Medicine, The Lancet, and eight other journals announced jointly last week that they would publish results of trials only if the experiments are

Print Subscription

Digital Subscription

Already have an account? Log In Now.